-
2
-
-
1842856019
-
Molecular footprints of human lung cancer progression
-
J. Yokota and T. Kohno, Molecular footprints of human lung cancer progression, Cancer Sci 95 (2004), 197-204.
-
(2004)
Cancer Sci
, vol.95
, pp. 197-204
-
-
Yokota, J.1
Kohno, T.2
-
3
-
-
0035181301
-
Prognostic molecular markers in non-small cell lung cancer
-
J. Niklinski, W. Niklinska, J. Laudanski, E. Chyczewska and L. Chyczewski, Prognostic molecular markers in non-small cell lung cancer, Lung Cancer 34 (2001), 53-58.
-
(2001)
Lung Cancer
, vol.34
, pp. 53-58
-
-
Niklinski, J.1
Niklinska, W.2
Laudanski, J.3
Chyczewska, E.4
Chyczewski, L.5
-
5
-
-
0033611560
-
Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma
-
Y. Tomizawa, T. Kohno, T. Fujita, M. Kiyama, R. Saito, M. Noguchi, Y. Matsuno, S. Hirohashi, N. Yamaguchi, T. Nakajima and J. Yokota, Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma, Oncogene 18 (1999), 1007-1014.
-
(1999)
Oncogene
, vol.18
, pp. 1007-1014
-
-
Tomizawa, Y.1
Kohno, T.2
Fujita, T.3
Kiyama, M.4
Saito, R.5
Noguchi, M.6
Matsuno, Y.7
Hirohashi, S.8
Yamaguchi, N.9
Nakajima, T.10
Yokota, J.11
-
6
-
-
0026680448
-
Clinical significance of ras oncogene activation in human lung cancer
-
S. Rodenhuis and R.J. Slebos, Clinical significance of ras oncogene activation in human lung cancer, Cancer Res 52 (1992), 2665-2669.
-
(1992)
Cancer Res
, vol.52
, pp. 2665-2669
-
-
Rodenhuis, S.1
Slebos, R.J.2
-
7
-
-
0036716816
-
hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer
-
L. Wang, J.C. Soria, B.L. Kemp, D.D. Liu, L. Mao and F.R. Khuri, hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer, Clin Cancer Res 8 (2002), 2883-2889.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2883-2889
-
-
Wang, L.1
Soria, J.C.2
Kemp, B.L.3
Liu, D.D.4
Mao, L.5
Khuri, F.R.6
-
8
-
-
0028564951
-
Specific association of human telomerase activity with immortal cells and cancer
-
N.W. Kim, M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, P.L. Ho, G.M. Coviello, W.E. Wright, S.L. Weinrich and J.W. Shay, Specific association of human telomerase activity with immortal cells and cancer, Science 266 (1994), 2011-2015.
-
(1994)
Science
, vol.266
, pp. 2011-2015
-
-
Kim, N.W.1
Piatyszek, M.A.2
Prowse, K.R.3
Harley, C.B.4
West, M.D.5
Ho, P.L.6
Coviello, G.M.7
Wright, W.E.8
Weinrich, S.L.9
Shay, J.W.10
-
9
-
-
0029072561
-
Telomerase activity in small-cell and non-small-cell lung cancers
-
K. Hiyama, E. Hiyama, S. Ishioka, M. Yamakido, K. Inai, A.F. Gazdar, M.A. Piatyszek and J.W. Shay, Telomerase activity in small-cell and non-small-cell lung cancers, J Natl Cancer Inst 87 (1995), 895-902.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 895-902
-
-
Hiyama, K.1
Hiyama, E.2
Ishioka, S.3
Yamakido, M.4
Inai, K.5
Gazdar, A.F.6
Piatyszek, M.A.7
Shay, J.W.8
-
10
-
-
0034831375
-
Association of p53 gene mutation and telomerase activity in resectable non- small cell lung cancer
-
Y. Maniwa, M. Yoshimura, C. Obayashi, M. Inaba, K. Kiyooka, M. Kanki and Y. Okita, Association of p53 gene mutation and telomerase activity in resectable non- small cell lung cancer, Chest 120 (2001), 589-594.
-
(2001)
Chest
, vol.120
, pp. 589-594
-
-
Maniwa, Y.1
Yoshimura, M.2
Obayashi, C.3
Inaba, M.4
Kiyooka, K.5
Kanki, M.6
Okita, Y.7
-
11
-
-
20444480258
-
distinct patterns in never, former, and current smokers
-
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke
-
F. Le Calvez, A. Mukeria, J.D. Hunt, O. Kelm, R.J. Hung, P. Taniere, P. Brennan, P. Boffetta, D.G. Zaridze and P. Hainaut, TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers, Cancer Res 65 (2005), 5076-5083.
-
(2005)
Cancer Res
, vol.65
, pp. 5076-5083
-
-
Le Calvez, F.1
Mukeria, A.2
Hunt, J.D.3
Kelm, O.4
Hung, R.J.5
Taniere, P.6
Brennan, P.7
Boffetta, P.8
Zaridze, D.G.9
Hainaut, P.10
-
12
-
-
24344494462
-
Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer
-
A.C. Laga, D.S. Zander, and P.T. Cagle, Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer, Arch Pathol Lab Med 129 (2005), 1113-1117.
-
(2005)
Arch Pathol Lab Med
, vol.129
, pp. 1113-1117
-
-
Laga, A.C.1
Zander, D.S.2
Cagle, P.T.3
-
13
-
-
0141562299
-
Lung cancer and cyclooxygenase-2
-
J.E. Castelao, R.D. Bart III, C.A. DiPerna, E.M. Sievers and R.M. Bremner, Lung cancer and cyclooxygenase-2, Ann Thorac Surg 76 (2003), 1327-1335.
-
(2003)
Ann Thorac Surg
, vol.76
, pp. 1327-1335
-
-
Castelao, J.E.1
Bart III, R.D.2
DiPerna, C.A.3
Sievers, E.M.4
Bremner, R.M.5
-
14
-
-
0032533858
-
Expression of cyclooxygenase-2 in human lung carcinoma
-
H. Wolff, K. Saukkonen, S. Anttila, A. Karjalainen, H. Vainio and A. Ristimaki, Expression of cyclooxygenase-2 in human lung carcinoma, Cancer Res 58 (1998), 4997-5001.
-
(1998)
Cancer Res
, vol.58
, pp. 4997-5001
-
-
Wolff, H.1
Saukkonen, K.2
Anttila, S.3
Karjalainen, A.4
Vainio, H.5
Ristimaki, A.6
-
15
-
-
0036191910
-
Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer
-
J. Brabender, J. Park, R. Metzger, P.M. Schneider, R.V. Lord, A.H. Holscher, K.D. Danenberg and P.V. Danenberg, Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer, Ann Surg 235 (2002), 440-443.
-
(2002)
Ann Surg
, vol.235
, pp. 440-443
-
-
Brabender, J.1
Park, J.2
Metzger, R.3
Schneider, P.M.4
Lord, R.V.5
Holscher, A.H.6
Danenberg, K.D.7
Danenberg, P.V.8
-
16
-
-
0032948381
-
Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas
-
H. Achiwa, Y. Yatabe, T. Hida, T. Kuroishi, K. Kozaki, S. Nakamura, M. Ogawa, T. Sugiura, T. Mitsudomi and T.Takahashi, Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas, Clin Canc Res 5 (1999), 1001-1005.
-
(1999)
Clin Canc Res
, vol.5
, pp. 1001-1005
-
-
Achiwa, H.1
Yatabe, Y.2
Hida, T.3
Kuroishi, T.4
Kozaki, K.5
Nakamura, S.6
Ogawa, M.7
Sugiura, T.8
Mitsudomi, T.9
Takahashi, T.10
-
17
-
-
3042665905
-
Cyclooxygenase as a target in lung cancer
-
J.R. Brown and R.N. DuBois, Cyclooxygenase as a target in lung cancer, Clin Canc Res 10 (2004), 4266-4269.
-
(2004)
Clin Canc Res
, vol.10
, pp. 4266-4269
-
-
Brown, J.R.1
DuBois, R.N.2
-
18
-
-
33748744068
-
Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer
-
H. Tsubochi, N. Sato, M. Hiyama, M. Kaimori, S. Endo, Y. Sohara and T. Imai, Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer, Ann Thorac Surg 82 (2006), 1198-1204.
-
(2006)
Ann Thorac Surg
, vol.82
, pp. 1198-1204
-
-
Tsubochi, H.1
Sato, N.2
Hiyama, M.3
Kaimori, M.4
Endo, S.5
Sohara, Y.6
Imai, T.7
-
20
-
-
17744385725
-
Alterations of K-ras and p53 mutations in colorectal cancer patients in Central Europe
-
E.A. König, I. Köves, A. Raşinariu, A.R. Popp, W.C. Kusser, K. Soyonki, A. Kovács, B.W. Glickman, A. Jeney and Z.L. Marcsek, Alterations of K-ras and p53 mutations in colorectal cancer patients in Central Europe, J Toxicol Environ Health A62 (2001), 333-347.
-
(2001)
J Toxicol Environ Health
, vol.A62
, pp. 333-347
-
-
König, E.A.1
Köves, I.2
Raşinariu, A.3
Popp, A.R.4
Kusser, W.C.5
Soyonki, K.6
Kovács, A.7
Glickman, B.W.8
Jeney, A.9
Marcsek, Z.L.10
-
21
-
-
33745815990
-
Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer
-
K.Y. Chen, L.N. Lee, C.J. Yu, Y.C. Lee, S.H. Kuo and P.C. Yang, Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer, Cancer Lett 240 (2006), 148-156.
-
(2006)
Cancer Lett
, vol.240
, pp. 148-156
-
-
Chen, K.Y.1
Lee, L.N.2
Yu, C.J.3
Lee, Y.C.4
Kuo, S.H.5
Yang, P.C.6
-
22
-
-
16544386625
-
Prognostic factors in resected stage I non-small-cell lung cancer: A multivariate analysis of six molecular markers
-
C. Lu, J.C. Soria, X. Tang, X.C. Xu, L. Wang, L. Mao, R. Lotan, B. Kemp, B.N. Bekele, L. Feng, W.K. Hong and F.R. Khuri, Prognostic factors in resected stage I non-small-cell lung cancer: a multivariate analysis of six molecular markers, J Clin Oncol 22 (2004), 4575-4583.
-
(2004)
J Clin Oncol
, vol.22
, pp. 4575-4583
-
-
Lu, C.1
Soria, J.C.2
Tang, X.3
Xu, X.C.4
Wang, L.5
Mao, L.6
Lotan, R.7
Kemp, B.8
Bekele, B.N.9
Feng, L.10
Hong, W.K.11
Khuri, F.R.12
-
23
-
-
0002092338
-
Prognostic markers in resected stage I and II non small-cell lung cancer: An analysis of 260 patients with 5 year follow-up
-
S.A. Mehdi, A.H. Tatum, N.B. Newman, G.P. Gamble, J.E. Etzell, N. Weidner, J.A. Kern, S.M. Sorscher, L.J. Kohman and S.L. Graziano, Prognostic markers in resected stage I and II non small-cell lung cancer: an analysis of 260 patients with 5 year follow-up, Clin Lung Cancer 1 (1999), 59-67.
-
(1999)
Clin Lung Cancer
, vol.1
, pp. 59-67
-
-
Mehdi, S.A.1
Tatum, A.H.2
Newman, N.B.3
Gamble, G.P.4
Etzell, J.E.5
Weidner, N.6
Kern, J.A.7
Sorscher, S.M.8
Kohman, L.J.9
Graziano, S.L.10
-
24
-
-
0031896297
-
Increased telomerase activity and absence of p53 mutation in oligoastrocytomas induced by N-ethyl-N-nitrosourea in rats
-
H. Sakitani, T. Tsujiuchi, K. Kobitsu, A. Kido, K. Iki, M. Takahama, M. Nakamura, T. Sakaki, D. Nakae, Y. Konishi and M. Tsutsumi, Increased telomerase activity and absence of p53 mutation in oligoastrocytomas induced by N-ethyl-N-nitrosourea in rats, Cancer Lett 126 (1998), 157-164.
-
(1998)
Cancer Lett
, vol.126
, pp. 157-164
-
-
Sakitani, H.1
Tsujiuchi, T.2
Kobitsu, K.3
Kido, A.4
Iki, K.5
Takahama, M.6
Nakamura, M.7
Sakaki, T.8
Nakae, D.9
Konishi, Y.10
Tsutsumi, M.11
-
25
-
-
0035171991
-
TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: Lessons from the IARC TP53 mutation database
-
P. Hainaut, M. Olivier and G.P. Pfeifer, TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database, Mutagenesis 6 (2001), 551-553.
-
(2001)
Mutagenesis
, vol.6
, pp. 551-553
-
-
Hainaut, P.1
Olivier, M.2
Pfeifer, G.P.3
-
26
-
-
0037220167
-
The TP53 gene, tobacco exposure, and lung cancer
-
S.Toyooka, T. Tsuda and A.F. Gazdar, The TP53 gene, tobacco exposure, and lung cancer, Hum Mutat 21 (2003), 229-239.
-
(2003)
Hum Mutat
, vol.21
, pp. 229-239
-
-
Toyooka, S.1
Tsuda, T.2
Gazdar, A.F.3
-
27
-
-
0028933103
-
Tobacco and cancer: Epidemiology and the laboratory
-
P.Vineis and N. Caporaso, Tobacco and cancer: epidemiology and the laboratory, Environ Health Perspect 103 (1995), 156-160.
-
(1995)
Environ Health Perspect
, vol.103
, pp. 156-160
-
-
Vineis, P.1
Caporaso, N.2
-
28
-
-
0027407823
-
K-ras mutations in human adenocarcinoma of the lung: Association with smoking and occupational exposure to asbestos
-
K. Husgafvel-Pursiainen, P. Hackman, M. Ridanpää, S. Anttila, A. Karjalainen, T. Partanen, O. Taikina-Aho, L. Heikkilä and H. Vainio, K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos, Int J Cancer 53 (1993), 250-256.
-
(1993)
Int J Cancer
, vol.53
, pp. 250-256
-
-
Husgafvel-Pursiainen, K.1
Hackman, P.2
Ridanpää, M.3
Anttila, S.4
Karjalainen, A.5
Partanen, T.6
Taikina-Aho, O.7
Heikkilä, L.8
Vainio, H.9
-
29
-
-
0034161419
-
Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic diseases
-
B.J. Blencowe, Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases, Trends Biochem Sci 25 (2000), 106-110.
-
(2000)
Trends Biochem Sci
, vol.25
, pp. 106-110
-
-
Blencowe, B.J.1
-
30
-
-
4344693159
-
Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs)
-
I.P. Gorlov, O.Y. Gorlova, M.L. Frazier and C.I. Amos, Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs), Mutat Res 554 (2004), 175-183.
-
(2004)
Mutat Res
, vol.554
, pp. 175-183
-
-
Gorlov, I.P.1
Gorlova, O.Y.2
Frazier, M.L.3
Amos, C.I.4
-
31
-
-
0042242582
-
ESEfinder: A web resource to identify exonic splicing enhancers
-
L. Cartegni, J. Wang, Z. Zhu, M.Q. Zhang and A.R. Krainer, ESEfinder: a web resource to identify exonic splicing enhancers, Nucleic Acid Research 31 (2003), 3568-3571.
-
(2003)
Nucleic Acid Research
, vol.31
, pp. 3568-3571
-
-
Cartegni, L.1
Wang, J.2
Zhu, Z.3
Zhang, M.Q.4
Krainer, A.R.5
-
32
-
-
33744536437
-
Ras up-regulation of cyclooxygenase-2
-
M.G. Backlund, J.R. Mann, D. Wang and R.N. Dubois, Ras up-regulation of cyclooxygenase-2, Methods Enzymol 407 (2005), 401-410.
-
(2005)
Methods Enzymol
, vol.407
, pp. 401-410
-
-
Backlund, M.G.1
Mann, J.R.2
Wang, D.3
Dubois, R.N.4
-
33
-
-
33751336335
-
Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer
-
M. Li, W. Liu, Y.F. Zhu, Y.L. Chen, B.Z. Zhang and R. Wang, Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer, Acta Oncol 45 (2006), 1115-1119.
-
(2006)
Acta Oncol
, vol.45
, pp. 1115-1119
-
-
Li, M.1
Liu, W.2
Zhu, Y.F.3
Chen, Y.L.4
Zhang, B.Z.5
Wang, R.6
-
34
-
-
8844230280
-
Mutant K-rasV12 increases COX-2, peroxides and DNA damage in lung cell
-
A. Maciag, G. Sithanandam and L.M. Anderson, Mutant K-rasV12 increases COX-2, peroxides and DNA damage in lung cell, Carcinogenesis 11 (2004), 2231-2237.
-
(2004)
Carcinogenesis
, vol.11
, pp. 2231-2237
-
-
Maciag, A.1
Sithanandam, G.2
Anderson, L.M.3
-
35
-
-
0041386110
-
TP53 and mutations in human cancer
-
K. Szymanska and P. Hainaut, TP53 and mutations in human cancer, Acta Biochim Pol 50 (2003), 231-238.
-
(2003)
Acta Biochim Pol
, vol.50
, pp. 231-238
-
-
Szymanska, K.1
Hainaut, P.2
-
36
-
-
0346455771
-
The MDM2-p53 interaction
-
U.M. Moll and O. Petrenko, The MDM2-p53 interaction, Mol Cancer Res 1 (2003), 1001-1008.
-
(2003)
Mol Cancer Res
, vol.1
, pp. 1001-1008
-
-
Moll, U.M.1
Petrenko, O.2
|